MoneyWorks4Me

Vasundhara Rasayans - Quaterly Results

28 May 2025 Evaluate
The Sales for the quarter ended March 2025 of Rs. 77.56 million declined by -30.37% from Rs. 111.39 millions.The company suffered a huge decline of -79.08% to Rs. 4.46  millions from Rs. 21.32 millions  of corresponding previous quarter.Operating profit for the quarter ended March 2025 decreased to 8.38 millions as compared to 30.13 millions of corresponding quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 77.56 111.39 -30.37 339.90 370.18 -8.18 339.90 370.18 -8.18
Other Income 8.32 7.44 11.83 23.51 19.41 21.12 23.51 19.41 21.12
PBIDT 8.38 30.13 -72.19 63.93 83.33 -23.28 63.93 83.33 -23.28
Interest 0.81 0.74 9.46 2.69 1.74 54.60 2.69 1.74 54.60
PBDT 7.57 29.39 -74.24 61.24 81.59 -24.94 61.24 81.59 -24.94
Depreciation 0.99 0.80 23.75 3.57 2.64 35.23 3.57 2.64 35.23
PBT 6.58 28.59 -76.98 57.67 78.95 -26.95 57.67 78.95 -26.95
TAX 2.12 7.27 -70.84 15.21 20.36 -25.29 15.21 20.36 -25.29
Deferred Tax 0.01 0.48 -97.92 0.01 0.48 -97.92 0.01 0.48 -97.92
PAT 4.46 21.32 -79.08 42.46 58.59 -27.53 42.46 58.59 -27.53
Equity 31.78 31.78 0.00 31.78 31.78 0.00 31.78 31.78 0.00
PBIDTM(%) 10.80 27.05 -60.06 18.81 22.51 -16.45 18.81 22.51 -16.45
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..